These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 2709814
1. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils. Dvorak AM, Ackerman SJ. Lab Invest; 1989 Apr; 60(4):557-67. PubMed ID: 2709814 [Abstract] [Full Text] [Related]
2. Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide. Dvorak AM, MacGlashan DW, Warner JA, Letourneau L, Morgan ES, Lichtenstein LM, Ackerman SJ. Clin Exp Allergy; 1997 Apr; 27(4):452-74. PubMed ID: 9146940 [Abstract] [Full Text] [Related]
3. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. Dvorak AM, Letourneau L, Login GR, Weller PF, Ackerman SJ. Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566 [Abstract] [Full Text] [Related]
4. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein. Dvorak AM, Furitsu T, Letourneau L, Ishizaka T, Ackerman SJ. Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770 [Abstract] [Full Text] [Related]
5. Ultrastructural localization of Charcot-Leyden crystal protein in human eosinophils and basophils. Calafat J, Janssen H, Knol EF, Weller PF, Egesten A. Eur J Haematol; 1997 Jan; 58(1):56-66. PubMed ID: 9020375 [Abstract] [Full Text] [Related]
6. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Dvorak AM, Weller PF, Monahan-Earley RA, Letourneau L, Ackerman SJ. Lab Invest; 1990 May; 62(5):590-607. PubMed ID: 2160562 [Abstract] [Full Text] [Related]
9. Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells. Leiferman KM, Gleich GJ, Kephart GM, Haugen HS, Hisamatsu K, Proud D, Lichtenstein LM, Ackerman SJ. J Immunol; 1986 Feb 01; 136(3):852-5. PubMed ID: 3510254 [Abstract] [Full Text] [Related]
12. Vesicular transport of Charcot-Leyden crystal protein in f-Met peptide-stimulated human basophils. Dvorak AM, MacGlashan DW, Warner JA, Letourneau L, Morgan ES, Lichtenstein LM, Ackerman SJ. Int Arch Allergy Immunol; 1997 Aug 01; 113(4):465-77. PubMed ID: 9250593 [Abstract] [Full Text] [Related]
13. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells. Zhou Z, Tenen DG, Dvorak AM, Ackerman SJ. J Leukoc Biol; 1992 Dec 01; 52(6):588-95. PubMed ID: 1464731 [Abstract] [Full Text] [Related]
18. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Leonidas DD, Elbert BL, Zhou Z, Leffler H, Ackerman SJ, Acharya KR. Structure; 1995 Dec 15; 3(12):1379-93. PubMed ID: 8747464 [Abstract] [Full Text] [Related]
19. Localization of granule proteins in human eosinophil bone marrow progenitors. Egesten A, Calafat J, Weller PF, Knol EF, Janssen H, Walz TM, Olsson I. Int Arch Allergy Immunol; 1997 Oct 15; 114(2):130-8. PubMed ID: 9338606 [Abstract] [Full Text] [Related]